Compare Moderna, Inc. (MRNA) vs Nutanix Inc (NTNX) Price & Performance

Moderna, Inc.Trade

Nutanix IncTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Nutanix Inc — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Nutanix Inc trades at $53.61 (market cap $14.90B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Moderna, Inc. is trading nearer its 52-week high, Nutanix Inc nearer its low. Which is the better fit depends on your goals.

	MRNA	NTNX
Market Cap	$23.60B	$14.90B
Sector	Health	Technology
52-Week High	$81.80	$81.12
52-Week Low	$22.36	$34.41
Enterprise Value	$19.70B	$14.41B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

NTNX

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Nutanix Inc

Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.